Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant Recipients.

CONCLUSIONS: Use of PPI was not associated with an increased rate of BMD loss in KTRs. Our results support previous findings that PPI use does not have a significant effect on bone mineral loss. PMID: 32485707 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32485707?dopt=Abstract

Source: American Journal of Nephrology - June 1, 2020 Category: Urology & Nephrology Authors: Lyu B, Hansen KE, Jorgenson MR, Astor BC Tags: Am J Nephrol Source Type: research